| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |